These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7875519)

  • 1. [Monoclonal anti-D immunoglobulin for prevention of hemolytic disease of the newborn].
    Olovnikova NI; Belkina EV; Berkovskiĭ AL; Lemeneva LN; Nikolaeva TL; Chertkov IL
    Gematol Transfuziol; 1994; 39(4):3-6. PubMed ID: 7875519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoglobulin G monoclonal human anti-rhesus Rho(D) to prevent rhesus-incompatibility].
    Olovnikova NI; Belkina EV; Drize NI; Konopliannikov AG; Lemeneva LN; Miterev GIu; Nikolaeva TL; Savel'eva GM; Chertkov IL
    Klin Med (Mosk); 1997; 75(7):39-43. PubMed ID: 9411052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.
    Kumpel BM; Saldova R; Koeleman CAM; Abrahams JL; Ederveen AH; Armour KL; Olovnikova NI; Vidarsson G; Kapur R; Rudd PM; Wuhrer M
    Sci Rep; 2020 Jan; 10(1):1464. PubMed ID: 32001734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn.
    Kumpel BM
    Transfus Clin Biol; 1997 Jul; 4(4):351-6. PubMed ID: 9269715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of Rh D-positive red cells with monoclonal anti-D.
    Thomson A; Contreras M; Gorick B; Kumpel B; Chapman GE; Lane RS; Teesdale P; Hughes-Jones NC; Mollison PL
    Lancet; 1990 Nov; 336(8724):1147-50. PubMed ID: 1978026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of human monoclonal IgG antibodies against Rhesus (D) antigen.
    Bron D; Feinberg MB; Teng NN; Kaplan HS
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3214-7. PubMed ID: 6427767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dwindling supplies of anti-D.
    Beveridge HE
    Med J Aust; 1997 Nov; 167(9):509-10. PubMed ID: 9397073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement from the consensus conference on anti-D prophylaxis. 7 and 8 April 1997. The Royal College of Physicians of Edinburgh. The Royal College of Obstetricians and Gynaecologists, UK.
    Vox Sang; 1998; 74(2):127-8. PubMed ID: 9501413
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue in inner space: management of Rh hemolytic disease.
    Liley HG
    J Pediatr; 1997 Sep; 131(3):340-2. PubMed ID: 9329405
    [No Abstract]   [Full Text] [Related]  

  • 18. [The number of neonates treated with exchange transfusion for hemolytic disease due to Rh isoimmunization before and after the administration of anti-Rho (D) immunoglobulin prophylactically].
    Hodr R
    Cesk Gynekol; 1986 Mar; 51(2):95-6. PubMed ID: 3006930
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens.
    Pasha RP; Roohi A; Shokri F
    Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.